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Abstract
Background: Hepatitis B is one of the most common infectious diseases in China. The aim of this study was to
determine the prevalence of hepatitis B surface antigen (HBsAg) among the general population and the risk factors
associated with HBV infection in Anhui province, China.
Methods: A provincial serosurvey was conducted in four cities, and selected through stratified clustering sampling.
Data on demographics, immunization history, medical history, family medical history, and life history were
collected, along with serum tested for HBsAg. Completed surveys were analysed from 8,875 participants.
Results: Overall prevalence of HBsAg was 7.44%. Using multivariate analysis, older age was a risk factor for HBsAg
infection among children younger than 15 years. Among adults 15-59 years old, the risk factors were male gender,
a history of surgical operations, at least one HBsAg-positive family member, and non-vaccination. For adults older
than 59 years, the risk factor was a blood transfusion history.
Conclusions: Though Anhui province has already reached the national goal of reducing HBsAg prevalence to less
than 1% among children younger than 5 years, there are still several risk factors for HBsAg infection among the
older population. Immunization programs should continue to focus on adults, and interventions should be taken
to reduce risk factors associated with being infected with Hepatitis B.
Background
I ns p i t eo fav a c c i n ea v a i l a b l ei n1 9 8 2 ,t h eh e p a t i t i sB
virus (HBV) remains a serious global public health pro-
blem. Worldwide, two billion people are currently
infected with HBV, 360 million have chronic infections
related to HBV, and 600,000 die each year from HBV-
related liver disease or hepatocellular carcinoma [1].
Hepatitis B is particularly endemic in China; the 1992
national serosurvey showed a population’sp r e v a l e n c eo f
9.75% [2]. That same year, 120 million Chinese were
HBsAg carriers, 20 million suffered from chronic hepati-
tis B, and almost 300,000 died annually from HBV-
related infections [2,3]. Hepatitis B is a major cause of
death for both liver cancer and cirrhosis, two infections
with high mortality rates in China [4].
1992 was also the year that the Ministry of Health
recommended a nationwide hepatitis B routine immuni-
zation [5]. Between 1992 and 2005, there were three
successive policies encouraging more parents to have
their infants vaccinated [6]. The first policy started in
1992 where parents paid for the vaccine and a user fee.
The second policy began in 2002 where parents only
paid for the user fee while the vaccine was still freely
available. The final policy was introduced in June 2005,
where the vaccine was free and the user fee was waived
to all parents. By then, China had fully integrated hepa-
titis B vaccination as part of its routine immunization
for infants. As such, by 2006, the prevalence of HBsAg
had dropped to 7.2% for those aged 1-59 years [7,8].
Most HBV infections in developed countries result
from sexual activity, injecting drug use, or occupational
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any medium, provided the original work is properly cited.exposure. In developing countries, other causes of infec-
tions can include household contact, vertical transmis-
sion hemodialysis, transmission from a surgeon [9], and
the receipt of organs or blood products [10]. Given
these various ways for HBV infection to occur within
any general population, control of hepatitis B is one of
the highest priorities in China. Thus far, however, no
studies have determined the risk factors of HBV infec-
tion on a regional level. Knowledge of such findings can
equip local governments with ways to modify national
immunization policies if needed.
Compared to other provinces, Anhui province, located
in east central China, has a medial incidence of HBV
infection [11]. To evaluate whether the impact of the
hepatitis B vaccination program since 1992 in Anhui
province is similar to the rest of the country, this paper
examined an updated Hepatitis B serosurvey to (1) mea-
sure the prevalence of hepatitis B among the general
population and (2) determine the ongoing risk factors
for hepatitis B infection.
Methods
Study participants and data collection
This cross-sectional study was performed during 2006,
and stratified cluster sampling was used to recruit parti-
cipants from four cities based on the geographic charac-
teristics of Anhui province. Anhui can roughly be
divided into three regions: the northern Huaihe river
area, the area between Yangtze and Huaihe Rivers, and
the southern Yangtze River area. Cluster sampling was
based on these three regions. The first level of stratifica-
tion sampling involved cities: one selected city in the
northern Huaihe River area, two in the area between the
Yangtze and Huaihe Rivers (a second city was selected
as this area was the most populous of the three), and
one in the southern Yangtze River area. In these four
cities, all streets in the urban areas and all towns in the
rural areas were ranked according to three grades (high,
medium, and low) based on the socio-economics of the
people living in each area. One urban street and one
rural town were then selected randomly from each
grade; this was the second level of stratification. The
final level of stratification was the random selection of
communities and administrative villages, with one com-
munity for each urban street and one administrative vil-
lage for each rural town. In total, 8,895 participants
were recruited from 12 communities and 12 administra-
tive villages. Participants were eligible as long as their
current residence was in one of the selected areas for
the survey.
To raise awareness of the HBV serosurvey, all selected
residents were informed twice, first by local leaders and
second by local doctors, a week before the actual admin-
istration. The serosurvey collection for each community
or administrative village covered four days. After
informed consent was obtained, all participants were
interviewed face-to-face by trained staff in a private
room. A standard questionnaire was used to compile
each participant’s demographic information and risk
factors.
Specimen collection and laboratory testing
Blood samples collected from each participant included
5 mL for those aged over 6 years, and 2 mL for children
aged 6 years or less. All blood samples were stored at 0°
C and transported to the Hepatitis Laboratory of the
Department for Bacteria and Viruses at the Anhui Acad-
emy of Medical Science in Hefei after each day’s survey-
ing. These serum specimens were screened for HBsAg
by enzyme-linked immunoabsorbent assays (ELISA).
ELISA reagents were purchased from the manufacturer
Shanghai Kehua company in China. For specimens with
inconsistent results, Abbott EIA reagents were used for
reconfirmation testing.
Statistical analysis
All data were inputted twice into an EPI Data 3.02 soft-
ware database [12]. After verifying its accuracy, SPSS
1 0 . 0s o f t w a r el o c a t e da tt h eE p idemiology and Statistics
Department of the School of Public Health at Anhui
Medical University was used for analysis. The prevalence
rates of HBV seromarkers included point estimates. To
identify factors that affected the prevalence of HBsAg
for all participants, separate multivariate logistic regres-
sions were analysed for populations aged 0-14 years, 15-
59 years, and 60+ years. The dependent variable was the
prevalence for HBsAg; the independent variables
included gender, location of community (urban vs.
rural), marriage status, occupation, education, unsafe
injections, history of operations, blood transfusion his-
tory, family members being HBsAg-positive, immuniza-
tion history, personal medical history, family medical
history, and life history. The significance level was set at
P < .05.
Quality control
Specialists from the Anhui provincial Centers for Dis-
ease Control (CDC), Anhui Medical University, the First
Affiliated Hospital of Anhui Medical University, Anhui
provincial Hospital, and the Anhui Academy of Medical
Science convened several times to discuss the statistical
design, epidemiological investigation, laboratory testing,
training, and analysis of this study. A field pilot study
was conducted before the actual survey, based on the
field survey’s Standard Operating Procedures (SOP), and
all staff was trained to conduct interviews; collect, store,
transport blood specimens; perform testing; and input
and analyse data.
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Medical Science Ethics Committee. Each participant was
informed of the survey’s purpose and their right to have
their information kept confidential. In addition, inter-
viewing, laboratory testing, and notification of results
were provided free to all participants. Test results were
enveloped, sealed, and delivered personally to each par-
ticipant by the local doctor. All participants received
small gifts as compensation for their participation.
Results
Characteristics of study participants
Almost all the enrolled participants (8,890 of 8,895)
completed the questionnaires and 8,882 blood samples
were collected. Completed questionnaires and blood
samples resulted in 8,875 eligible datasets (99.8%). The
overall prevalence of HBsAg was 7.44%.
Characteristics of the participants are shown in Table
1. Nearly three-quarters (72.9%) were aged 15-59 years.
The male to female ratio was 0.76:1, and 99.7% were of
Han ethnicity. The percentages of participants who
reported having received hepatitis B vaccination were
higher among children less than 15 years old (82.9%)
than adults aged 15-59 years (29.9%) and those over 60
years of age (5.8%).
Prevalence of HBsAg by demographic characteristics
Figure 1 shows that the prevalence of HBsAg varied by
age group. Prevalence was lowest among children less
than 5 years old (0.3%) and highest among those aged
60-69 years (9.3%).
T h ep r e v a l e n c eo fH B s A gw a ss i g n i f i c a n t l yh i g h e rf o r
males (8.2%) than for females (6.8%, P < 0.01) (Table 2).
The only other significant finding was that the prevalence
of HBsAg among vaccinated participants was lower (6.2%)
than among unvaccinated participants (8.7%, P < 0.01).
Multivariate analyses of HBsAg status
Among the 0-14 age group, the only significant predic-
tor was age: children aged 10-14 years had a signifi-
cantly higher prevalence of HBsAg than children aged
5-9 years (OR = 13.78, P < 0.05), and children aged 5-9
years had a higher prevalence for HBsAg than children
aged 0-4 years (OR = 7.15, P < 0.10) (Table 3).
For participants aged 15-59 years, several factors sig-
nificantly contributed to having HBsAg: gender (male),
(OR = 1.47, P < 0.01), a history of surgical operations
(OR = 1.24, P < 0.05), having at least one HBsAg-posi-
tive family member (OR = 2.04, P < 0.01), and being
unvaccinated (OR = 1.51, P < 0.01) (Table 4).
Among adults aged 60+ years, the only significant pre-
dictor of HBsAg was having any blood transfusion his-
tory (OR = 2.48, P < 0.05) (Table 5).
Table 1 Characteristics of study participants
Variable Frequency Percentage
Age (years) 0-4 318 3.6
5-14 656 7.4
15-59 6 472 72.9
60+ 1 429 16.1
Urban/Rural Urban 4 285 48.3
Rural 4 590 51.7
Gender Male 3 838 43.2
Female 5 037 56.8
Ethnicity Han 8 845 99.7
Other 30 0.3
Occupation Worker 2 332 29.5
Farmer 3 208 40.6
Student 1 155 14.6
Civil servant 516 6.5
Health worker 20 0.3
Service worker 201 2.5
Other 469 5.9
Education Illiterate 2 119 26.8
Primary school 1 318 16.7
Middle school 2 078 26.3
High school 1 304 16.5
College 1 082 13.7
Marriage status Unmarried 1 186 15.0
Married 6 173 78.1
Dissociation/Loss of
spouse
542 6.9
Vaccinated (0-14) Yes 807 82.9
No 167 17.1
Vaccinated (15-
59)
Yes 1 934 29.9
Variable Frequency Percentage
No 4 538 70.1
Vaccinated (60+) Yes 83 5.8
No 1 346 94.2
Figure 1 HBsAg prevalence among participants by age group.
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In 1992, the World Health Organization (WHO) recom-
mended the integration of the hepatitis B vaccine into
the national immunization programs of all highly ende-
mic countries by 1995 [13]. Following the WHO’s
recommendation, the HBsAg prevalence in China fell
among children born after 1992 [7] and more so for
children born after 2002, when the hepatitis B vaccine
was fully integrated into routine infant immunization
Table 2 HBsAg prevalence by demographic characteristics
Variable Frequency Prevalence (%)
Urban/Rural Urban 4 285 7.5
Rural 4 590 7.4
Gender Male 3 838 8.2*
Female 5 037 6.8
Ethnicity Han 8 845 7.4
Other 30 10.0
Occupation (for age group 15-59 years) Worker 2 331 8.7
Farmer 2 083 8.2
Student 1 155 6.1
Civil servant 428 7.5
Health worker 14 14.3
Service worker 177 5.6
Other 284 10.2
Occupation (60+) Worker 1 0.0
Farmer 1 125 8.6
Civil servant 88 4.5
Health worker 6 16.7
Service worker 24 0.0
Other 185 9.7
Education (aged 15-59 years) Illiterate 1 304 7.1
Primary school 953 8.7
Middle school 1 908 8.2
Middle school
High school 1 247 9.1
College 1 060 6.7
Education (60+) Illiterate 815 7.6
Primary school 365 9.9
Middle school 170 8.2
High school 57 10.5
College 22 9.1
Marriage status (15-59) Unmarried 1 161 7.4
Married 5 137 7.9
Widowed 174 13.2
Marriage status (60+) Unmarried 25 8.0
Married 1 036 8.8
Widowed 368 7.3
Vaccinated (0-14) Yes 807 2.0
No 167 4.2
Vaccinated (15+) Yes 2 017 6.2*
No 5 884 8.7
* P < 0.01
Table 3 Multivariate logistic regression analysis of HBsAg
prevalence for participants aged 0-14 years
Variable Category OR 95% CI for OR P value
Lower Upper
Age group 0-4* 1
5-9 7.15 0.86 59.77 0.069
10-14 13.78 1.82 104.51 0.011
*Reference category; Adjusted variables: gender, location of community,
immunization history.
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vince, HBsAg prevalence among children aged 0-4 years
is merely 0.3%, which is lower than children aged 5 and
up.
The carrier rate for HBsAg is 7.44% among all partici-
pants. To compare this figure with the national serosur-
vey, the carrier rate in our paper was standardized based
on the 2002 national population constituent ratio, which
was 6.56%. The standardized rate for HBsAg prevalence
among the general population aged 1-59 years is 6.71%,
which is lower than the national serosurvey rate in 2006
and lower than the rates from the Anhui serosurveys in
1979 and 1992. Again, we attribute the falling rates to
the universal immunization program for infants. The
prevalence of HBsAg is low among children age < 5
years but this increases with age, which indicates an
inverse relationship between age and likelihood of vacci-
nation. This suggests the need for an immunization
program to encourage both older children and adult
populations to be vaccinated as well. The Chinese gov-
ernment is currently implementing policies aimed at
these populations to control hepatitis B, such as HBsAg
screening of blood for transfusion, control of blood
exposure in medical settings, and the management and
treatment of HBV-infected persons [14].
The multivariate logistic regression analysis revealed
that among children, the main risk factor for HBsAg
positivity is age. Children aged 0-4 have more access to
the hepatitis B vaccine and a better hepatitis B vaccine
service than children aged 5 onwards. Thus is because
the routine Expanded Programme on Immunization
(EPI) has both improved and been more emphasized
since 2002. In addition, the financial barriers to vaccina-
tion have become less of an issue because of the recent
rising economic development in Anhui province. More
pregnant women are being screened for HBsAg, and
better medical records are being kept. This allows a hos-
pital to determine if the expectant mother requires test-
ing if HBsAg screening was not previously performed.
T h ei n f a n t so ft h o s ew o m e nf o u n dp o s i t i v ew i l lt h e nb e
given the HBsAg vaccine and Hepatitis B Immunoglobu-
lin (HBIG) within 24 hours after birth.
Among adults aged 16-59 years, the risk factors
include being male, a history of operations, a family
member who is HBsAg positive, and not being immu-
nized. These factors are in agreement with recent sero-
prevalence studies [15,16]. Among adults aged 60+ years
old, the greatest risk factor was a history of blood trans-
fusions. This finding suggests that horizontal HBV
transmission and health-care-related factors are mainly
r e s p o n s i b l ef o rt h ep r e v a l e n c ea m o n ga l la d u l t s .H o r i -
zontal transmission and mother-to-infant transmission
of HBV are demonstrated by strong family clustering
occurring through frequent exposure to blood (e.g.,
through contact with skin lesions), saliva (e.g., through
sharing of toothbrushes and candy), or breast milk
[17,18]. These factors are not specific to resource-poor
settings, as it has also been described within families liv-
ing in the United States and Europe [19-21].
Health-care-related transmission has long been recog-
nized as an important source of new HBV infections
worldwide. While most HBV transmissions have
occurred during invasive surgical or obstetric procedures
[1], our findings indicate that people with any opera-
tional history are also at risk for HBV infection. There
are three possible routes for infection during an opera-
tion: the first from a surgeon to a patient, the second
from contaminated surgical instruments to a patient,
a n dt h et h i r df r o ma nH B V - p o s i t i v ep a t i e n tt oa n o t h e r
patient staying in the same hospital room [22-24].
Throughout China, nosocomial infection control is con-
ducted stringently in provincial and municipal level
Table 4 Multivariate logistic regression analysis of HBsAg
prevalence for participants aged 15-59 years
Variable Category OR 95% CI for
OR
P
value
Lower Upper
Gender Male* 1
Female 0.68 0.57 0.82 <
0.001
Unsafe injections No* 1
Yes 1.23 0.99 1.51 0.053
History of operations No * 1
Yes 1.24 1.00 1.53 0.048
Blood transfusion history No* 1
Yes 1.57 0.98 2.53 0.060
Family member is HBsAg
positive
No* 1
Yes 2.04 1.55 2.68 <
0.001
Immunization history No* 1
Yes 0.66 0.53 0.83 <
0.001
*Reference category; Adjusted variables: location of community, marriage
status, occupation, education, family medical history, and life history.
Table 5 Multivariate logistic regression analysis of HBsAg
prevalence for participants aged 60+ years
Variable Category OR 95% CI for OR P value
Lower Upper
Unsafe injections No* 1
Yes 1.76 0.97 3.18 0.06
Blood transfusion history No* 1
Yes 2.48 1.07 5.76 0.04
*Reference category; Adjusted variables: gender, location of community,
marriage status, occupation, education, history of operations, family members
being HBsAg-positive, immunization history, personal medical history, family
medical history, and life history.
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level hospitals as well as several private hospitals where
invasive surgical or obstetric procedures are frequently
performed [25,26]. Surgeon-to-patient transmissions of
hepatitis B were essentially eliminated when the vaccina-
tion of health care workers became routine [27]. How-
ever, preventing all health-care-related transmissions of
HBV requires a comprehensive approach that includes
administering nosocomial infections, consistently pro-
viding hepatitis B vaccination to healthcare personnel,
enforcing stricter measures to reduce blood exposure
between healthcare workers and patients, and having all
surgical teams committed to promoting and maintaining
a safe work environment constantly [28,29].
An interesting finding is that a history of blood trans-
fusions is the greatest risk factor for HBV infection
among adults who are more than 59 years old. Although
recent investigations have suggested that blood transfu-
sion remains a major risk factor, at least partly due to
the presence of occult HBV infection (OBI) among
blood donors [30], blood transfusions have become safer
in recent decades in China due to the issuing of laws
and regulations [31]. The Ministry of Health initially
introduced routine strict serum HBsAg screening in all
blood centres in the early 1980s. By 1998, the Law for
Donating Blood was issued, enacting regulations for the
Management of Blood in Clinical Facility and further
enhancing the safety of blood transfusions and safety in
the use of serum related products. Transfusion-related
HBV infection caused by unsafe blood has been satisfac-
torily controlled thereafter [31]. However, serological
screening of blood donors was first performed in a few
blood centres as early as in the late 1970s, and many
people could have been infected then before regulations
were established. As such, the higher prevalence rates
among the elderly could in part be attributed to pre-
vious contaminated blood transfusions.
The carrier rate for HBsAg was 2.0% among vacci-
nated participants aged 0-14 years, and 6.2% over 15
years. This suggests that 141 vaccinated participants
failed to respond to the hepatitis B vaccine, and became
sero-positive for HBsAg. One possibility is that hepatitis
B vaccine did not have an effect on certain people.
Another is that several hepatitis B vaccines were not
preserved well in cool chains, causing it to be ineffective.
A third may be that a number of HBV infected persons
did not know their infected status. Although the number
is small, failed responses to the vaccine may warrant
further investigation.
One limitation of our study is that HBsAg prevalence
may be overestimated among children and underesti-
mated among adults because younger participants with
HBV infection were more likely to be brought to the
survey site by their parents or other guardians, while
vaccinated adult participants were less likely to take part
in our survey. Another is recall bias. Participants were
first asked, “Were you vaccinated with the hepatitis B
vaccine?”, followed by, “Did you receive 3 injections?”,
and finally, “When were you vaccinated?” If the answers
for the first two questions are both “yes,” the participant
will be included in the vaccinated variable. Thus, some
unvaccinated participants may end up becoming vacci-
nated participants.
Conclusions
The integration of the hepatitis B vaccine into China’s
routine immunization programs has significantly
decreased the HBsAg carrier rate among children born
after 1992 in Anhui province. In order to reduce HBV
infections further, the routine immunization programs
among children need to be continued and mass immu-
nization should be emphasized for all. These steps
would reduce the circulation of the virus in the commu-
nity and allow the average age at infection among those
who were not immunized to increase. In addition, health
education should focus more on dealing with HBV-posi-
tive family members, and nosocomial infections and
blood transfusion safety should be strictly controlled
and ensured by all hospitals and the local governments.
Careful screening of blood products for hepatitis B
should continue to be emphasized, and new strategies
for HBV blood donor screening be applied universally
[32]. The management of unresponsive subjects should
be strengthened [33], and the need for routine booster
doses should be improved among adults for future vac-
cination policies.
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